Edit search
A randomised phase III study on capecitabine%2C oxaliplatin …
A randomised phase III study on capecitabine%2C oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer%2C the CAIRO2 study of the Dutch Colorectal Cancer Group %28DCCG%29. An interim analysis of toxicity.
A randomised phase III study on capecitabine%2C oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer%2C the CAIRO2 study of the Dutch Colorectal Cancer Group %28DCCG%29. An interim analysis of toxicity.
Article, Chapter
Authors: Tol
Publication: Annals of Oncology
Published: Elsevier
ISSN: 0923-7534
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item